A detailed history of Versant Capital Management, Inc transactions in Illumina, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 95 shares of ILMN stock, worth $12,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 330 71.21%
Holding current value
$12,921
Previous $34,000 64.71%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$105.28 - $135.9 $24,740 - $31,936
-235 Reduced 71.21%
95 $12,000
Q2 2024

Jul 05, 2024

BUY
$101.05 - $133.57 $24,858 - $32,858
246 Added 292.86%
330 $34,000
Q3 2023

Oct 11, 2023

SELL
$128.91 - $192.44 $1,675 - $2,501
-13 Reduced 13.4%
84 $11,000
Q2 2023

Jul 10, 2023

BUY
$183.43 - $232.67 $2,384 - $3,024
13 Added 15.48%
97 $18,000
Q1 2022

Apr 29, 2022

SELL
$303.87 - $423.8 $1,215 - $1,695
-4 Reduced 4.55%
84 $29,000
Q4 2021

Jan 06, 2022

SELL
$347.28 - $421.83 $347 - $421
-1 Reduced 1.12%
88 $33,000
Q3 2021

Oct 29, 2021

SELL
$405.61 - $524.84 $405 - $524
-1 Reduced 1.11%
89 $36,000
Q2 2021

Jul 22, 2021

BUY
$372.84 - $481.5 $372 - $481
1 Added 1.12%
90 $43,000
Q1 2021

Apr 27, 2021

BUY
$361.28 - $504.76 $1,806 - $2,523
5 Added 5.95%
89 $34,000
Q2 2019

Jul 16, 2019

SELL
$300.59 - $368.15 $12,624 - $15,462
-42 Reduced 33.33%
84 $30,000
Q1 2019

Apr 23, 2019

BUY
$272.57 - $321.18 $23,713 - $27,942
87 Added 223.08%
126 $39,000
Q1 2019

Apr 23, 2019

SELL
$272.57 - $321.18 $23,713 - $27,942
-87 Reduced 69.05%
39 $39,000
Q3 2018

Oct 15, 2018

SELL
$279.04 - $367.06 $23,997 - $31,567
-86 Reduced 40.57%
126 $46,000
Q2 2018

Jul 06, 2018

SELL
$228.17 - $292.07 $912 - $1,168
-4 Reduced 1.85%
212 $59,000
Q1 2017

Apr 23, 2018

SELL
N/A
-12 Reduced 5.26%
216 $36,000
Q4 2016

Apr 23, 2018

SELL
N/A
-41 Reduced 15.24%
228 $29,000
Q4 2015

Apr 23, 2018

BUY
N/A
269
269 $51,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.